Ken Griffin Pet Iq, Inc. Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$20.57 - $30.79 $742,577 - $1.11 Million	36,100 Added 530.88%	42,900 $1.32 Million
Q2 2024 Aug 14, 2024	SELL	$15.93 - $22.26 $52,569 - $73,458	-3,300 Reduced 32.67%	6,800 $150,000
Q1 2024 May 15, 2024	SELL	$15.55 - $19.42 $18,660 - $23,304	-1,200 Reduced 10.62%	10,100 $184,000
Q4 2023 Feb 14, 2024	BUY	$17.18 - $22.38 $8,590 - $11,190	500 Added 4.63%	11,300 $223,000
Q3 2023 Nov 14, 2023	BUY	$15.0 - $20.71 $16,500 - $22,781	1,100 Added 11.34%	10,800 $212,000
Q2 2023 Aug 14, 2023	SELL	$10.84 - $15.43 $118,156 - $168,187	-10,900 Reduced 52.91%	9,700 $147,000
Q1 2023 May 15, 2023	SELL	$9.32 - $12.58 $148,188 - $200,022	-15,900 Reduced 43.56%	20,600 $235,000
Q4 2022 Feb 14, 2023	BUY	$6.82 - $12.07 $26,598 - $47,073	3,900 Added 11.96%	36,500 $336,000
Q3 2022 Nov 14, 2022	BUY	$6.9 - $18.16 $57,960 - $152,544	8,400 Added 34.71%	32,600 $225,000

189

30M

81K

113K

Ticker PETQ
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,312,800
Market Cap $908M
Description
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medicat...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.